Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer (Q34563201)

3 August 2017

title

Activated lymphocyte recruitment into the tumor microenvironment following preoperative sipuleucel-T for localized prostate cancer (English)

1 reference

3 August 2017

1 reference

13

Eric J Small

1 reference

3 August 2017

Lawrence Fong

1

1 reference

3 August 2017

Peter Carroll

2

1 reference

3 August 2017

Vivian Weinberg

3

1 reference

3 August 2017

Stephen Chan

4

1 reference

3 August 2017

Jera Lewis

5

1 reference

3 August 2017

John Corman

6

1 reference

3 August 2017

Christopher L Amling

7

1 reference

3 August 2017

Robert A Stephenson

8

1 reference

3 August 2017

Jeffrey Simko

9

1 reference

3 August 2017

Nadeem A Sheikh

10

1 reference

3 August 2017

Robert B Sims

11

1 reference

3 August 2017

Mark W Frohlich

12

1 reference

3 August 2017

language of work or name

English

0 references

publication date

24 September 2014

1 reference

Journal of the National Cancer Institute

3 August 2017

published in

1 reference

3 August 2017

volume

106

1 reference

3 August 2017

issue

11

1 reference

Characteristics of tertiary lymphoid structures in primary cancers

3 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241888

Cancer classification using the Immunoscore: a worldwide task force

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241888

PD-1 blockade enhances T-cell migration to tumors by elevating IFN-γ inducible chemokines

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241888

Sipuleucel-T immune parameters correlate with survival: an analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241888

Targeting the PD-1/B7-H1(PD-L1) pathway to activate anti-tumor immunity

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241888

CTLA4 blockade induces frequent tumor infiltration by activated lymphocytes regardless of clinical responses in humans

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241888

Sipuleucel-T immunotherapy for castration-resistant prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241888

Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241888

Human prostate-infiltrating CD8 T lymphocytes are oligoclonal and PD-1 .

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241888

Safety and immunological efficacy of a DNA vaccine encoding prostatic acid phosphatase in patients with stage D0 prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241888

Chemokine expression in melanoma metastases associated with CD8 T-cell recruitment

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241888

Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241888

Effector memory T cells, early metastasis, and survival in colorectal cancer

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241888

The University of California, San Francisco Cancer of the Prostate Risk Assessment score: a straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4241888

Dendritic cell-based xenoantigen vaccination for prostate cancer immunotherapy

7 July 2018

1 reference

In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer

21 January 2018

1 reference

The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment

21 January 2018

1 reference

12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy?

21 January 2018

1 reference

Predictive gene signature in MAGE-A3 antigen-specific cancer immunotherapy

21 January 2018

1 reference

A pilot trial of CTLA-4 blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer

21 January 2018

1 reference

Tumour-infiltrating lymphocytes: A prognostic factor of PSA-free survival in patients with local prostate carcinoma treated by radical prostatectomy

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25255802

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1093/JNCI/DJU268

1 reference

3 August 2017

1 reference

3 August 2017

1 reference